These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28079846)

  • 21. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.
    Natalini JG; Swigris JJ; Morisset J; Elicker BM; Jones KD; Fischer A; Collard HR; Lee JS
    Respir Med; 2017 Jun; 127():1-6. PubMed ID: 28502413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.
    Cox IA; Borchers Arriagada N; de Graaff B; Corte TJ; Glaspole I; Lartey S; Walters EH; Palmer AJ
    Eur Respir Rev; 2020 Dec; 29(158):. PubMed ID: 33153990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
    Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
    Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial.
    Moor CC; Mostard RLM; Grutters JC; Bresser P; Aerts JGJV; Chavannes NH; Wijsenbeek MS
    Am J Respir Crit Care Med; 2020 Aug; 202(3):393-401. PubMed ID: 32325005
    [No Abstract]   [Full Text] [Related]  

  • 25. R-scale for pulmonary fibrosis: a simple, visual tool for the assessment of health-related quality of life.
    Scallan C; Strand L; Hayes J; Kadura S; Collins B; Ho L; Spada C; Canestaro W; Kolb M; Raghu G
    Eur Respir J; 2022 Jan; 59(1):. PubMed ID: 34112729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis.
    Gvozdenovic BS; Mihailovic-Vucinic V; Ilic-Dudvarski A; Zugic V; Judson MA
    Respir Med; 2008 Nov; 102(11):1636-42. PubMed ID: 18691860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of the walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis: a feasibility study.
    Wapenaar M; Bendstrup E; Molina-Molina M; Stessel MKN; Huremovic J; Bakker EW; Kardys I; Aerts JGJV; Wijsenbeek MS
    Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):192-202. PubMed ID: 33093783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of palliative care on quality of life, anxiety, and depression in idiopathic pulmonary fibrosis: a randomized controlled pilot study.
    Janssen K; Rosielle D; Wang Q; Kim HJ
    Respir Res; 2020 Jan; 21(1):2. PubMed ID: 31900187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translation and validation of the King's Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch.
    Wapenaar M; Patel AS; Birring SS; Domburg RTV; Bakker EW; Vindigni V; Sköld CM; Cottin V; Vancheri C; Wijsenbeek MS
    Chron Respir Dis; 2017 May; 14(2):140-150. PubMed ID: 28019103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health-Related Quality of Life in Sarcoidosis.
    Obi ON
    Semin Respir Crit Care Med; 2020 Oct; 41(5):716-732. PubMed ID: 32583381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory and non-respiratory symptoms in patients with IPF or sarcoidosis and controls.
    Bloem AEM; Houben-Wilke S; Mostard RLM; Stoot N; Janssen DJA; Franssen FME; Custers JWH; Spruit MA
    Heart Lung; 2023; 61():136-146. PubMed ID: 37269615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry.
    Case AH; Hellkamp AS; Neely ML; Bender S; Dilling DF; Gulati M; Hotchkin DL; Huie TJ; Lancaster L; Snyder LD; Conoscenti CS; Palmer SM
    Ann Am Thorac Soc; 2020 Jun; 17(6):699-705. PubMed ID: 32040340
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners.
    Lindell KO; Olshansky E; Song MK; Zullo TG; Gibson KF; Kaminski N; Hoffman LA
    Heart Lung; 2010; 39(4):304-13. PubMed ID: 20561836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The St. George's Respiratory Questionnaire as a prognostic factor in IPF.
    Furukawa T; Taniguchi H; Ando M; Kondoh Y; Kataoka K; Nishiyama O; Johkoh T; Fukuoka J; Sakamoto K; Hasegawa Y
    Respir Res; 2017 Jan; 18(1):18. PubMed ID: 28095852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary and psychosocial findings at enrollment in the ACCESS study.
    Yeager H; Rossman MD; Baughman RP; Teirstein AS; Judson MA; Rabin DL; Iannuzzi MC; Rose C; Bresnitz EA; DePalo L; Hunninghakes G; Johns CJ; McLennan G; Moller DR; Newman LS; Rybicki B; Weinberger SE; Wilkins PC; Cherniack R;
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Jun; 22(2):147-53. PubMed ID: 16053031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The COPD Assessment Test (CAT) can screen for fatigue among patients with COPD.
    Stridsman C; Svensson M; Johansson Strandkvist V; Hedman L; Backman H; Lindberg A
    Ther Adv Respir Dis; 2018; 12():1753466618787380. PubMed ID: 30035671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe Fatigue is Highly Prevalent in Patients with IPF or Sarcoidosis.
    Bloem AEM; Mostard RLM; Stoot N; Vercoulen JH; Peters JB; Janssen DJA; Custers JWH; Spruit MA
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32325989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depression Is Significantly Associated with the Health Status in Patients with Idiopathic Pulmonary Fibrosis.
    Matsuda T; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Nishimura K; Nishiyama O; Sakamoto K; Hasegawa Y
    Intern Med; 2017; 56(13):1637-1644. PubMed ID: 28674350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The utility of selected questionnaires in the assessment of fatigue, depression and health quality in post-sarcoidosis fatigue syndrome.
    Górski W; Mokros Ł; Kumor-Kisielewska A; Pietras T; Piotrowski WJ
    Adv Respir Med; 2017; 85(6):313-321. PubMed ID: 29288480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perceptions of fatigue in patients with idiopathic pulmonary fibrosis or sarcoidosis.
    Bloem AEM; Mostard RLM; Stoot N; Vercoulen JH; Peters JB; Spruit MA
    J Thorac Dis; 2021 Aug; 13(8):4872-4884. PubMed ID: 34527326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.